ScoreWhy is ImmuCell Corp. ?
1
Weak Long Term Fundamental Strength with a 28.32% CAGR growth in Operating Profits over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -1.93
- The company has been able to generate a Return on Equity (avg) of 0.66% signifying low profitability per unit of shareholders funds
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is ImmuCell Corp. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
ImmuCell Corp.
13.76%
0.14
63.63%
S&P 500
13.22%
0.61
20.17%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
14.32%
EBIT Growth (5y)
28.32%
EBIT to Interest (avg)
-1.93
Debt to EBITDA (avg)
1.67
Net Debt to Equity (avg)
0.21
Sales to Capital Employed (avg)
0.57
Tax Ratio
4.06%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
15.89%
ROCE (avg)
0.87%
ROE (avg)
0.66%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.05
EV to EBIT
-65.36
EV to EBITDA
26.30
EV to Capital Employed
1.87
EV to Sales
2.39
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-0.63%
ROE (Latest)
-0.94%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend24What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 2.53 MM
PRE-TAX PROFIT(Q)
At USD 0.5 MM has Grown at 872.83%
NET PROFIT(Q)
At USD 0.5 MM has Grown at 839.87%
ROCE(HY)
Highest at 6.61%
RAW MATERIAL COST(Y)
Fallen by -98.88% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at 27.68 %
-1What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for ImmuCell Corp.
Pre-Tax Profit
At USD 0.5 MM has Grown at 872.83%
over average net sales of the previous four periods of USD -0.07 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (USD MM)
Net Profit
At USD 0.5 MM has Grown at 839.87%
over average net sales of the previous four periods of USD -0.07 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Operating Cash Flow
Highest at USD 2.53 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Debt-Equity Ratio
Lowest at 27.68 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by -98.88% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
